MIAMI, FL--(NewMediaWire - May 9, 2017) - Novus
Acquisition and Development, Corp. (OTC PINK: NDEV) ("Novus"), through its wholly owned
subsidiary WCIG Insurance Services, Inc., is a diversified
insurance entity in health, liability, annuity and accident, and,
the nation's first carrier/aggregator offering a cannabis health
plan, today announced that it is permitted to market its health
benefits packages in the state of Florida.
NOVUS
Health |Life | Liability
Novus has begun its entry into what is expected to be the second
largest cannabis revenue generating state in the U.S. and become a
major player in the cannabis sector that will rival the current
markets of Colorado and California.
Many analysts project that Florida's cannabis market will grow
to $1.6 billion by 2020 at a compound annual growth rate of 140%;
making it at least half the size of California's projected $2.6
billion and projecting Florida to be 7.5% of the total legal U.S.
cannabis market by 2020.
Sources:
https://www.forbes.com/sites/debraborchardt/2016/12/09/florida-medical-marijuana-sales-could-rival-colorado-by-2020/#3323464194d3
This is supported by many companies coming into Florida, such as
publicly-traded Aphria, a Canadian-based cannabis cultivator that
plans to purchase and invest $25 million into a Florida cultivation
facility that values the state cannabis license at close to $200
million.
As Novus continues to invest into the expansion of its
infrastructure, this move into Florida will increase its projected
23 million Americans to 30 million by 2018, once markets are fully
developed.
Novus CEO, Frank Labrozzi, stated, "Novus' business model in the
cannabis health insurance is based on owning receivables (insurance
policies) rather than depreciative assets such as hard inventory,
manufacturing, delivery vehicles and warehousing that all can weigh
heavy on a company's intrinsic value. Along with recent
announcements that the U.S. Department Of Justice and U.S. Attorney
General Jeff Sessions are getting their hands tied by Congress with
no funds for the fight against patients that need medical cannabis,
this sure points to signs that medical cannabis in the United
States is here to stay."
Novus and the State of Healthcare from the U.S. Federal
Government
As it stands many insurance companies, Aetna and Humana for
example, are opting out of ObamaCare, leaving millions of Americans
without health insurance. This also includes many Americans
currently opting out of ObamaCare, for reasons of higher premiums,
deductibles, and pharmaceutical coverages. Whether it's
ObamaCare or TrumpCare, it does not matter, Novus will continue to
design its plans to fill the gaps and seek the inefficiencies and
take advantage of the country's current healthcare
shortcomings.
Novus MedPlan not only covers medical cannabis, but also dental,
vision, hearing, diabetic, lab and imaging packages that rival many
government-subsidized healthcare plans. In the foreseeable future,
Novus plans to announce new benefit packages that will cover many
Americans even if ObamaCare is repealed and/or placed.
We invite you to review the entire filing
here: https://www.otcmarkets.com/stock/NDEV/filings
About Novus
Novus Acquisition & Development Corp. (OTC
PINK: NDEV), through its subsidiary WCIG Insurance,
provides health insurance and related insurance solutions within
the wellness and medical marijuana industries in states where legal
programs exist. Novus has developed its infrastructure within many
lines of the insurance business such as, health, property &
casualty, life, accident and fixed annuities.
Novus medical cannabis benefits package will work as outside
developers and will not cultivate, handle, transport grow, extract,
dispense, put up for sale, put on the market, vend, deliver,
supply, circulate, or trade cannabis or any substances that violate
the United States law or the Controlled Substances Act, nor does it
intend to do so in the future and will continue to follow state and
federal laws. The statements made about specific products have not
been evaluated by the United States Food and Drug Administration
(FDA) and are not intended to diagnose, treat, cure or prevent
disease. All information provided on these press releases or any
information contained on or in any product label or packaging is
for informational purposes only and is not intended as a substitute
for advice from your physician or other health care professional.
Once a push notification is competed the transaction is solely
between the state-licensed dispensary and the registered
patient.
The state laws are in conflict with the federal Controlled
Substances Act. The current administration has effectively stated
that it is not an efficient use of resources to direct federal law
enforcement agencies to prosecute those lawfully abiding by state
designated laws, allowing the use and distribution of medical
marijuana. However, there is no guarantee that the current
administration, nor any future administration, will not change this
policy and decide to enforce the federal laws strongly. Any such
change in the federal government's enforcement of current federal
laws could cause significant financial changes to Novus Medical
Group. While we do not intend to harvest, distribute or sell
cannabis or cannabis related products, we may be harmed by a change
in enforcement by federal or state governments.
For more information, please visit: http://www.getnovusnow.com
View Filings: https://www.otcmarkets.com/stock/NDEV/filings
Learn How Insurance Companies Are Evaluated: http://bit.ly/2ddIYva
Forward-Looking Statements
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions and growth rates; uncertainty as to
whether our strategies and business plans will yield the expected
benefits; increasing competition; availability and cost of capital;
the ability to identify and develop and achieve commercial success;
the level of expenditures necessary to maintain and improve the
quality of services; changes in the economy; changes in laws and
regulations, includes codes and standards, intellectual property
rights, and tax matters; or other matters not anticipated; our
ability to secure and maintain strategic relationships and
distribution agreements. Novus Medical Group disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
